The appointment puts a CEO known for raising huge sums of cash in charge of a well-regarded bispecific antibody R&D shop.
The startup, founded just last year and a JLABS alumnus, is working on next-gen tech.
HiFiBiO Therapeutics has had a busy year, as pacts and raises abound, and it’s showing no signs of slowing down as it gets its checkbook out for an unusual…
An FDA advisory committee recommended AcelRx's Dsuvia, a sublingual version of sufentanil, for approval in a 10-3 vote.
The FDA approved a molecular diagnostic test that can match blood donors using patient DNA.
Scientists have demonstrated how mutations in cell proteins known as “splicing factors” can cause the eye disease retinitis pigmentosa.
In the wake of Hurricane Michael, the two largest dialysis companies in the country have opened their doors to all patients seeking treatment.
DFCI's Haining to become VP, Oncology at Merck; Pfizer poaches Quest exec to spearhead digital; and Perrigo swaps CEO for former tobacco executive.
The reverse merger comes six months after Adynxx committed to advancing pain drug brivoligide, despite the candidate coming up short in phase 2.
The tiny offering will equip Hoth to test a topical formulation of the broad-spectrum antibiotic gentamicin in a phase 2 eczema trial.